Correction of hyper- and hyponatraemia during continuous renal replacement therapy.

Nephron Clinical Practice Pub Date : 2014-01-01 Epub Date: 2015-01-10 DOI:10.1159/000369347
Carole Dangoisse, Helen Dickie, Linda Tovey, Marlies Ostermann
{"title":"Correction of hyper- and hyponatraemia during continuous renal replacement therapy.","authors":"Carole Dangoisse,&nbsp;Helen Dickie,&nbsp;Linda Tovey,&nbsp;Marlies Ostermann","doi":"10.1159/000369347","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Severe hyper- and hyponatraemia is associated with significant risks, yet its correction can also have serious consequences when implemented too fast or inadequately. The safe correction of serum sodium levels is particularly challenging when renal replacement therapy (RRT) is required.</p><p><strong>Methods: </strong>Using 2 case scenarios, we aim to illustrate a simple method of correcting hyper- and hyponatraemia safely by step-wise manipulation of the dialysate/replacement fluid.</p><p><strong>Results: </strong>During continuous RRT, hypernatraemia can be corrected effectively and safely by adding small pre-calculated amounts of 30% NaCl to the dialysate/replacement fluid bags aiming for a [Na(+)] in the fluid that allows safe equilibration and correction of the serum [Na(+)]. To correct hyponatraemia safely, pre-calculated amounts of sterile water can be added in a step-wise manner to achieve a fluid [Na(+)] that equals the desired target serum [Na(+)].</p><p><strong>Conclusion: </strong>During continuous RRT, the step-wise adjustment of [Na(+)] of dialysate/replacement fluids offers a safe and reliable method to correct sodium disorders.</p>","PeriodicalId":19094,"journal":{"name":"Nephron Clinical Practice","volume":"128 3-4","pages":"394-8"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000369347","citationCount":"26","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephron Clinical Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000369347","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2015/1/10 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 26

Abstract

Background: Severe hyper- and hyponatraemia is associated with significant risks, yet its correction can also have serious consequences when implemented too fast or inadequately. The safe correction of serum sodium levels is particularly challenging when renal replacement therapy (RRT) is required.

Methods: Using 2 case scenarios, we aim to illustrate a simple method of correcting hyper- and hyponatraemia safely by step-wise manipulation of the dialysate/replacement fluid.

Results: During continuous RRT, hypernatraemia can be corrected effectively and safely by adding small pre-calculated amounts of 30% NaCl to the dialysate/replacement fluid bags aiming for a [Na(+)] in the fluid that allows safe equilibration and correction of the serum [Na(+)]. To correct hyponatraemia safely, pre-calculated amounts of sterile water can be added in a step-wise manner to achieve a fluid [Na(+)] that equals the desired target serum [Na(+)].

Conclusion: During continuous RRT, the step-wise adjustment of [Na(+)] of dialysate/replacement fluids offers a safe and reliable method to correct sodium disorders.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
持续肾替代治疗中高、低钠血症的纠正。
背景:严重的高钠血症和低钠血症与重大风险相关,但如果实施得过快或不充分,其纠正也会产生严重后果。当需要肾替代治疗(RRT)时,安全校正血清钠水平尤其具有挑战性。方法:采用两种情况,我们的目的是说明一个简单的方法纠正高钠血症和低钠血症安全逐步操作透析液/替代液。结果:在持续RRT过程中,通过在透析液/替代液袋中加入预先计算的少量30% NaCl,可有效、安全地纠正高钠血症,使液体中的[Na(+)]得以安全平衡和纠正血清[Na(+)]。为了安全地纠正低钠血症,可以逐步加入预先计算好的无菌水,以使液体[Na(+)]等于所需的目标血清[Na(+)]。结论:在连续RRT中,逐步调整透析液/替代液[Na(+)]是一种安全可靠的纠正钠紊乱的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Nephron Clinical Practice
Nephron Clinical Practice 医学-泌尿学与肾脏学
自引率
0.00%
发文量
0
审稿时长
6-12 weeks
期刊最新文献
Comparison of Outcomes of In-Centre Haemodialysis Patients between the 1st and 2nd COVID-19 Outbreak in England, Wales, and Northern Ireland: A UK Renal Registry Analysis Association of Serum Triglycerides and Renal Outcomes among 1.6 Million US Veterans Genetic Deletion of the Stromal Cell Marker CD248 (Endosialin) Protects against the Development of Renal Fibrosis Contents Vol. 128, 2014 Author Index Vol. 127, No. 1-4, 2014
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1